Lung disease an acute COVID-19 development factor: study

By Farid Farid
Updated May 18 2022 - 9:57am, first published 8:34am
A Sydney study looked at the effect of COVID-19 on chronic obstructive pulmonary disease patients.
A Sydney study looked at the effect of COVID-19 on chronic obstructive pulmonary disease patients.

Around 400 million people worldwide suffering from a specific lung disease are nearly 25 times more likely to develop acute COVID-19, a new study by Sydney scientists has found.

Get the latest Senior news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.